Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Wall St. edges lower in choppy session

02/26/2019 | 04:39pm EDT
Traders work on the floor of the NYSE in New York

NEW YORK (Reuters) - Wall Street's three major indexes fell slightly after a choppy session on Tuesday as investors eyed mixed U.S. economic data and corporate news and waited for clarity on issues such as the U.S.-China trade talks.

By Sinéad Carew

Weaker-than-expected housing data contrasted with a rosy consumer confidence report, while Home Depot Inc was among the biggest drags on the benchmark S&P 500 index after the home improvement retailer blamed bad weather for missed Wall Street forecasts.

Federal Reserve Chairman Jerome Powell told a U.S. Senate Banking Committee that the central bank would remain "patient" in deciding on further interest rate hikes and that rising risks and recent soft data should not prevent solid growth for the economy this year.

The indexes have already been bolstered in recent weeks by trade optimism and dovish signals from the Fed, with the S&P 500's session high just 4.7 percent away from its record closing high in September.

"Investors are a little tentative as far as chasing the market higher. They're waiting for better prices or better news," said Michael O'Rourke, chief market strategist at JonesTrading in Greenwich, Connecticut.

He cited issues such as a need for specifics on U.S.-China trade relations after President Donald Trump said on Sunday he would delay an increase in U.S. tariffs on Chinese goods after "productive" trade talks.

Sameer Samana, senior global market strategist at Wells Fargo Investment Institute in St. Louis, also cited uncertainty over reports that Trump's former personal attorney Michael Cohen would tell lawmakers this week that Trump asked him about a proposed skyscraper project in Moscow long after he had secured the Republican presidential nomination.

"You've higher uncertainty today relative to yesterday," said Samana. "The economic data was mixed. We've had a market rally going on for about two months. All those things together suggest this would be a good time to take some profits. It's not wholesale selling but profit taking around the edges."

The Dow Jones Industrial Average fell 33.97 points, or 0.13 percent, to 26,057.98, the S&P 500 lost 2.21 points, or 0.08 percent, to 2,793.9 and the Nasdaq Composite dropped 5.16 points, or 0.07 percent, to 7,549.30.

Seven of the 11 major S&P sectors ended lower with industrials providing the biggest drag with a 0.3 percent drop. The benchmark's biggest boost was the technology index, which closed up 0.2 percent.

The healthcare index declined 0.3 percent after a U.S. congressional hearing on the prices of medicines wrapped up in Washington. Declines in shares of health insurers Cigna Corp and UnitedHealth Group, both of which operate major pharmacy benefit managers, were big drags on the sector.

The S&P's biggest losing stock was JPMorgan Chase & Co, which closed down 0.8 percent after it warned of rising costs for deposits, a key part of its business, and slowing global economic growth.

Caterpillar Inc fell 2.4 percent and also depressed the benchmark after brokerage UBS downgraded the stock to "sell" from a "buy" rating.

U.S. homebuilding tumbled to a more than two-year low in December as construction of both single and multifamily housing declined, the latest sign that the economy had lost momentum in the fourth quarter.

But the Conference Board's consumer confidence index rose more than expected in February.

Declining issues outnumbered advancing ones on the NYSE by a 1.29-to-1 ratio. On Nasdaq, a 1.56-to-1 ratio favored decliners.

The S&P 500 posted 16 new 52-week highs and one new low. The Nasdaq Composite recorded 45 new highs and 21 new lows.

Volume on U.S. exchanges was 7.05 billion shares, compared to the 7.3 billion average for the last 20 trading days.

(Additional reporting by Lewis Krauskopf in New York, Shreyashi Sanyal and Medha Singh in Bengaluru; Editing by Anil D'Silva, Susan Thomas and Richard Chang)

By Sinéad Carew

ę Reuters 2019
Stocks mentioned in the article
ChangeLast1st jan.
BYD COMPANY LIMITED 0.31% 259 End-of-day quote.27.46%
CATERPILLAR INC. 1.67% 208.539 Delayed Quote.12.71%
CIGNA CORPORATION 1.64% 233.12 Delayed Quote.10.17%
DISCOVERY, INC. -4.50% 27.77 Delayed Quote.-3.32%
DJ INDUSTRIAL 0.48% 34999.22 Delayed Quote.14.14%
NASDAQ 100 0.53% 15044.74178 Real-time Quote.16.07%
NASDAQ COMP. 0.39% 14739.640587 Real-time Quote.13.85%
S&P 500 0.46% 4406.78 Delayed Quote.17.02%
UNITEDHEALTH GROUP 0.85% 418.99 Delayed Quote.18.50%
WELLS FARGO & COMPANY 1.55% 46.505 Delayed Quote.51.72%
07/30CIGNA : Announces Updates to its Board of Directors (Form 8-K)
07/30DAVID CORDANI : Cigna Names CEO Cordani Chairman
07/30CIGNA CORP : Change in Directors or Principal Officers, Other Events, Financial ..
07/30Cigna Corporation Appoints Neesha Hathi as an Independent Member of the Board
07/30Cigna Corporation Announces Management Changes
07/30Cigna Corporation Announces Updates to Its Board of Directors
07/28Cigna Corporation Declares Quarterly Dividend, Payable on September 23, 2021
07/22Cigna and Oscar Health, Inc. Launches Oscar Virtual Primary Care on Select Ci..
07/15CIGNA : Bonnie Evelyn Named Cigna Market President for Georgia/Alabama
07/13Cigna Appoints Bonnie Evelyn as Market President for Its Health Care and Rela..
More news
Financials (USD)
Sales 2021 167 B - -
Net income 2021 5 430 M - -
Net Debt 2021 24 363 M - -
P/E ratio 2021 14,5x
Yield 2021 2,18%
Capitalization 78 700 M 78 700 M -
EV / Sales 2021 0,62x
EV / Sales 2022 0,56x
Nbr of Employees 72 963
Free-Float 86,0%
Duration : Period :
Cigna Corporation Technical Analysis Chart | CI | US1255231003 | MarketScreener
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 25
Last Close Price 229,35 $
Average target price 295,00 $
Spread / Average Target 28,6%
EPS Revisions
Managers and Directors
David Michael Cordani President, Chief Executive Officer & Director
Brian C. Evanko Chief Financial Officer & Executive Vice President
Isaiah Harris Independent Chairman
Steven B. Miller Chief Clinical Officer & Executive Vice President
Noelle K. Eder Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
ANTHEM, INC.19.60%95 159
HUMANA INC.3.80%55 203